All In Biotech

Drug Trial Radar · NCT06122831

A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)

A Phase Ib/II Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Intermediate- and High-risk Myelofibrosis

Last checked: Nov 19, 2026Latest source record: Dec 8, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

92

Planned (sponsor's estimate)

Start

Dec 12, 2023

Primary completion

Dec 2026

Study completion Apr 2027

Sponsor

Sponsor type
Industry
First posted
Nov 8, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an open, single-arm, multi-center clinical study designed to evaluate the efficacy and safety of TQ05105 Tablets combined with TQB3617 Capsules in patients with intermediate- and high-risk Myelofibrosis.

Conditions

  • Myelofibrosis

Interventions

  • TQ05105 TabletsDrug

    TQ05105 Tablets is a Janus kinase 1 (JAK1) and Janus kinase 2 (JAK2) Inhibitor.

  • TQB3617 CapsulesDrug

    TQB3617 Capsules is a Bromodomain and Extra-Terminal (BET) Inhibitor

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximal tolerance dose (MTD)Time frame: Up to 2 years.
  2. Recommended phase II dose (RP2D)Time frame: Up to 2 years
  3. ≥35% reduction in spleen volume (SVR35)Time frame: Up to 24 weeks

Locations

22 sites in 1 country. Site status is shown where the registry gives one.

  • Guangdong Provincial People's Hospital

    Guangzhou, Guangdong, China · Not yet recruiting

  • Guangxi Zhuang Autonomous Region People's Hospital

    Nanning, Guangxi, China · Not yet recruiting

  • Cangzhou People's Hosipital

    Cangzhou, Hebei, China · Not yet recruiting

  • Affiliated Hospital of Chengde Medical College

    Chengde, Hebei, China · Not yet recruiting

  • North China of Science and Technology University Affiliated Hospital

    Tangshan, Hebei, China · Not yet recruiting

  • Xingtai People's Hospital

    Xingtai, Hebei, China · Not yet recruiting

  • The First Hospital of Harbin

    Harbin, Heilongjiang, China · Not yet recruiting

  • Henan Cancer Hospital

    Zhengzhou, Henan, China · Not yet recruiting

  • Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology

    Wuhan, Hubei, China · Not yet recruiting

  • Union Hospital Tongji College Huazhong Unizersity of Science And Technology

    Wuhan, Hubei, China · Not yet recruiting

  • Wuhan University Zhongnan Hospital

    Wuhan, Hubei, China · Not yet recruiting

  • The Affiliated Hospital of Inner Mongolia Medical University

    Hohhot, Inner Mongolia, China · Not yet recruiting

  • The Public Hospital of Wuxi

    Wuxi, Jiangsu, China · Not yet recruiting

  • The First Hospital of Jilin University

    Changchun, Jilin, China · Not yet recruiting

  • Xi 'An Jiaotong University Second Affiliated Hospital

    Xi'an, Shaanxi, China · Not yet recruiting

  • Tai'an City Central Hospital

    Tai’an, Shandong, China · Not yet recruiting

  • Central Hospital Of Minhang District, Shanghai

    Shanghai, Shanghai Municipality, China · Not yet recruiting

  • Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine

    Shanghai, Shanghai Municipality, China · Recruiting

  • Shanghai Sixth People's Hospital

    Shanghai, Shanghai Municipality, China · Recruiting

  • Heping Hospital Affiliated to Changzhi Medical College

    Changzhi, Shanxi, China · Not yet recruiting

  • People's Hospital of Tianjin City

    Tianjin, Tianjin Municipality, China · Not yet recruiting

  • The First Affiliated Hospital of Xinjiang Medical University

    Ürümqi, Xinjiang, China · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.